Stockscreener 앱 받기
1.26
1.95%
-0.025
전일 마감가:
$1.285
열려 있는:
$1.28
하루 거래량:
307.12K
Relative Volume:
0.31
시가총액:
$134.56M
수익:
$4.35M
순이익/손실:
$-45.53M
주가수익비율:
-1.1667
EPS:
-1.08
순현금흐름:
$-44.79M
1주 성능:
-1.56%
1개월 성능:
-12.50%
6개월 성능:
+33.33%
1년 성능:
+35.53%
1일 변동 폭
$1.25
$1.30
1주일 범위
$1.19
$1.31
52주 변동 폭
$0.681
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
LUCD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.26 | 134.56M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
132.41 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.41 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.77 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.58 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.36 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Kilgore News Herald
PAVmed Sets Key Q1 2025 Earnings Call: MedTech Growth Strategy and Financial Results Coming May 15 - Stock Titan
Lucid Diagnostics to Reveal Q1 2025 Financial Results and Growth StrategyKey Details for Investors - Stock Titan
Lucid reports encouraging results from EsoGuard study - MSN
Lucid Diagnostics (LUCD) Showcases Promising Data for EsoGuard T - GuruFocus
A look into Lucid Diagnostics Inc (LUCD)’s deeper side - Sete News
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - BioSpace
PAVmed, Lucid post encouraging results from EsoGuard study (LUCD:NASDAQ) - Seeking Alpha
Lucid Reports Positive Data For EsoGuard Esophageal DNA Test In Patients Without Symptomatic GERD - Nasdaq
Lucid DiagnosticsNarrowing Losses, Expanding Opportunities In Esophageal Cancer Care - RTTNews
Did Lucid Diagnostics Inc (LUCD) perform well in the last session? - uspostnews.com
Lucid Diagnostics (NASDAQ:LUCD) Price Target Raised to $7.50 at Ascendiant Capital Markets - Defense World
Stock Performance Spotlight: Lucid Diagnostics Inc (LUCD) Ends the Day at 1.21, Up by 11.01 - DWinneX
Lucid Diagnostics (LUCD) Sees Price Target Increase Amid Growth Potential | LUCD Stock News - GuruFocus
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - ADVFN
PAVmed Provides Business Update and Second Quarter 2024 Financial Results - ADVFN
Lucid Diagnostics finalizes public offering of common stock - Medical Buyer
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - The Bradford Era
Lucid Diagnostics Closes $16.1 Million Public Offering - MSN
Lucid Diagnostics completes $16.1 million stock offering By Investing.com - Investing.com South Africa
Lucid Diagnostics Raises $16.1 Mln Through Public Offering To Support Corporate Growth - Nasdaq
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc (LUCD) With A Potential Upside Of More Than -100.0% - stocksregister.com
Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Benzinga
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - GuruFocus
Lucid Diagnostics completes $16.1 million stock offering - Investing.com Australia
Lucid Diagnostics Announces Closing Of Public Offering Of Common Stock - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Lucid Diagnostics Shares Fall After Pricing Stock Offering - marketscreener.com
Lucid Diagnostics Announces Public Stock Offering - TipRanks
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - MSN
Lucid Diagnostics Announces Proposed Public Offering of Common Stock - The Malaysian Reserve
Lucid Diagnostics announces proposed public offering of common stock - MSN
Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock - MarketScreener
Lucid Diagnostics plans stock offering to boost capital By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces Proposed Public Offering of Common S - GuruFocus
SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow
Lucid Diagnostics plans stock offering to boost capital - Investing.com Australia
Lucid Diagnostics Announces Proposed Public Offering Of Common Stock - MarketScreener
Commercial-Stage Cancer Prevention Company Lucid Diagnostics Unveils Strategic Funding Move - Stock Titan
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
Lucid Diagnostics stock soars to 52-week high of $1.64 - Investing.com Australia
Lucid Diagnostics stock soars to 52-week high of $1.64 By Investing.com - Investing.com South Africa
Pavmed Inc Files For Offering Of 3.3 Million Shares Of Common Stock - marketscreener.com
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.59%
0.04%
자본화:
|
볼륨(24시간):